Conference item icon

Conference item

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Publication status:
Published

Actions


Authors



Host title:
EUROPEAN JOURNAL OF CANCER
Volume:
49
Pages:
S402-S402
Publication date:
2013-09-01
ISSN:
0959-8049


Pubs id:
pubs:441205
UUID:
uuid:a036a469-47fa-4e6d-adb6-f7e8f26e55a7
Local pid:
pubs:441205
Source identifiers:
441205
Deposit date:
2013-12-11

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP